Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Hypercoagulability of COVID-19 and Neurological Complications: A Review
Patrick Moore1, Fatema Esmail1, Shuai Qin1
1Loyola University Medical Center Department of Internal Medicine Division of Hematology and Oncology, United States.
Insights
The SARS-CoV-2 virus, causing COVID-19, can lead to severe neurologic complications. This review examines COVID-19
Area of Science:
- Neurology
- Infectious Diseases
- Virology
Background:
- The emergence of SARS-CoV-2 has led to millions of deaths globally.
- Hospitalized COVID-19 patients frequently exhibit acute changes in mental status, cognition, and encephalopathy.
- Neurologic complications may arise from systemic infection severity, direct viral invasion of the CNS, or immune-mediated mechanisms.
Purpose of the Study:
- To review the current understanding of neurologic complications associated with SARS-CoV-2 infection.
- To explore the relationship between COVID-19 and hemostasis.
- To discuss current treatment, prevention, and vaccination strategies for COVID-19.
Main Methods:
- Literature review of existing research on COVID-19 and its neurological effects.
- Analysis of studies investigating the mechanisms behind COVID-19-related neurological complications.
- Examination of data on hemostasis, treatment, prevention, and vaccination in the context of COVID-19.
Main Results:
- Neurologic manifestations are a significant concern in COVID-19 patients.
- Multiple pathways, including direct viral invasion and immune responses, contribute to neurological damage.
- Understanding COVID-19's impact on hemostasis is crucial for patient management.
Conclusions:
- COVID-19 poses a substantial risk for neurological complications.
- Further research is needed to fully elucidate the mechanisms and optimize management strategies.
- Comprehensive approaches including vaccination are vital for controlling the pandemic.
Abstract:
The SARS-CoV-2 virus, which causes Coronavirus disease 2019 (COVID-19), has resulted in millions of worldwide deaths. When the SARS-CoV-2 virus emerged from Wuhan, China in December 2019, reports of patients with COVID-19 revealed that hospitalized patients had acute changes in mental status, cognition, and encephalopathy. Neurologic complications can be a consequence from overall severity of the systemic infection, direct viral invasion of the SARS-CoV-2 virus in the central nervous system, and possible immune mediated mechanisms. We will examine the landscape regarding this topic in this review in addition to current understandings of COVID-19 and hemostasis, treatment, and prevention, as well as vaccination.
Related Concept Videos
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

